Cardiovascular Drugs Practice Questions

Q: Why should a patient on verapamil not be given a beta-blocker?

Conduction block. **Explanation:** The combination of **Verapamil** (a non-dihydropyridine calcium channel blocker) and **Beta-blockers** is contraindicated because both drugs exert potent negative inotropic, negative chronotropic, and negative dromotropic effects. 1. **Why Conduction Block is Correct:** Both drugs act on the Sinoatrial (SA) and Atrioventricular (AV) nodes. Verapamil blocks L-type calcium channels, while beta-blockers inhibit sympathetic stimulation. When used together, their synergistic effect significantly slows AV conduction and depresses myocardial contractility. This can lead to severe **bradycardia, high-grade AV block, or even asystole.** 2. **Why other options are incorrect:** * **Bronchospasm:** While beta-blockers (especially non-selective ones like Propranolol) can cause bronchospasm, Verapamil does not exacerbate this effect; in fact, calcium channel blockers are generally safe in asthmatics. * **Neurogenic Shock:** This is caused by a loss of sympathetic tone (usually due to spinal cord injury). While the drug combination causes hypotension, it does not trigger the specific pathophysiology of neurogenic shock. * **Anaphylaxis:** This is a Type I hypersensitivity reaction. Neither drug is specifically known to trigger anaphylaxis when combined. **High-Yield Clinical Pearls for NEET-PG:** * **Dihydropyridines (e.g., Amlodipine):** These can be safely combined with beta-blockers because they primarily cause peripheral vasodilation and do not significantly depress the AV node. * **Drug of Choice:** Verapamil is the drug of choice for **Prophylaxis of PSVT**, but it must never be given intravenously to a patient already on oral beta-blockers. * **Antidote:** In cases of severe toxicity/blockade from this combination, **Intravenous Calcium** or **Glucagon** may be used to increase heart rate and contractility.

Q: In a patient with poor glycemic control, hypertriglyceridemia, and low HDL, which of the following drug regimens would be best to manage dyslipidemia without the risk of myositis as a side effect?

Nicotinic acid. **Explanation:** The patient presents with **diabetic dyslipidemia**, characterized by hypertriglyceridemia and low HDL levels [4]. **1. Why Nicotinic Acid (Niacin) is correct:** Nicotinic acid is the most potent agent for increasing **HDL levels** (by 15-35%) and is highly effective at lowering triglycerides [3]. Unlike statins and fibrates, nicotinic acid is not primarily associated with **myositis** or rhabdomyolysis when used as monotherapy. It works by inhibiting adipose tissue lipolysis and reducing hepatic VLDL synthesis. **2. Why the other options are incorrect:** * **Fibric acid derivatives (Fibrates):** While they are the first-line treatment for isolated hypertriglyceridemia, they carry a significant risk of **myopathy and myositis**, especially in patients with renal impairment or when combined with other drugs [2]. * **Atorvastatin & Simvastatin (Statins):** These are the gold standard for lowering LDL. However, **myalgia and myositis** are their most well-known dose-dependent side effects. In a patient specifically concerned about myositis risk, statins are less ideal than Niacin for managing the TG/HDL axis. **3. NEET-PG High-Yield Pearls:** * **Side Effects of Niacin:** The most common side effect is **cutaneous flushing** (mediated by Prostaglandin $D_2$), which can be prevented by taking **Aspirin** 30 minutes prior. It can also cause **hyperuricemia** (precipitating gout) and **hyperglycemia** (worsening glycemic control—a key caution in diabetics) [1]. * **Myositis Risk:** The risk of myositis increases exponentially when **Statins are combined with Fibrates** (especially Gemfibrozil) because fibrates inhibit the glucuronidation of statins, increasing their plasma levels [2]. * **Drug of Choice:** For isolated high TG, Fibrates are DOC; for high LDL, Statins are DOC; for increasing HDL, Niacin is most effective [3].

Q: Which of the following drugs is used for the prophylaxis of migraine but not for angina pectoris?

Flunarizine. **Explanation:** The correct answer is **Flunarizine**. **1. Why Flunarizine is correct:** Flunarizine is a **non-selective calcium channel blocker (CCB)** that also possesses antihistaminic, anti-dopaminergic, and anti-serotonergic properties. Unlike the CCBs used in cardiology, Flunarizine primarily acts on the central nervous system. It prevents intracellular calcium overload in neurons, which stabilizes neuronal activity and inhibits the "cortical spreading depression" associated with migraine pathogenesis. However, it has **no significant effect on systemic vascular resistance or myocardial oxygen demand**, making it ineffective for the treatment or prophylaxis of angina pectoris. **2. Why the other options are incorrect:** * **Verapamil (Phenylalkylamine):** This is a cardioselective CCB. It is used for angina (by reducing heart rate and contractility) and is also a first-line drug for the prophylaxis of **cluster headaches** and occasionally migraine. * **Diltiazem (Benzothiazepine):** This drug has intermediate effects on both the heart and blood vessels. It is a standard treatment for angina pectoris but is not typically used for migraine prophylaxis. * **Amlodipine (Dihydropyridine):** This is a potent peripheral vasodilator used extensively for chronic stable angina and hypertension. It has no established role in migraine prophylaxis. **3. High-Yield Clinical Pearls for NEET-PG:** * **Side Effects of Flunarizine:** Due to its anti-dopaminergic activity, it can cause **extrapyramidal symptoms (drug-induced Parkinsonism)** and significant weight gain/sedation. It should be avoided in patients with a history of depression or Parkinson’s disease. * **Drug of Choice:** While Flunarizine is used for migraine prophylaxis, **Propranolol** (a beta-blocker) remains the first-line agent. * **Verapamil Unique Use:** It is the prophylactic drug of choice for **Cluster Headache**, not just migraine.

Q: Which of the following is a true statement regarding Atrioventricular block with atrial tachycardia?

Seen in Digitalis toxicity with potassium depletion. **Explanation:** The combination of **Atrial Tachycardia (AT) with Atrioventricular (AV) block** is considered the most characteristic (pathognomonic) arrhythmia of **Digitalis toxicity**, especially when associated with **hypokalemia (potassium depletion)**. **Why the correct answer is right:** Digoxin has a dual effect on cardiac tissue: 1. **Increased Automaticity:** It increases intracellular calcium, leading to delayed after-depolarizations (DADs). This triggers rapid firing in the atria, causing Atrial Tachycardia. 2. **Decreased Conduction:** It increases vagal tone and directly inhibits the AV node, leading to a prolonged PR interval or AV block. While most tachyarrhythmias show 1:1 conduction, Digitalis is unique because it simultaneously stimulates the atria while depressing the AV node, resulting in the classic "PAT with block." Hypokalemia exacerbates this by increasing digoxin binding to the Na+/K+ ATPase pump. **Why the other options are wrong:** * **Option A:** WPW syndrome is characterized by an accessory pathway (Bundle of Kent) which typically leads to tachyarrhythmias *without* AV block (e.g., AVRT). * **Option B:** Pacemaker complications usually involve lead displacement, infection, or "pacemaker syndrome," but not specifically AT with AV block. * **Option C:** While isolated PACs or first-degree blocks can occur in healthy individuals, the specific combination of AT with AV block always signifies underlying pathology or drug toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Most common arrhythmia in Digoxin toxicity:** Ventricular Bigeminy. * **Most characteristic/specific arrhythmia:** Atrial Tachycardia with AV block. * **Electrolyte triggers:** Hypokalemia, Hypercalcemia, and Hypomagnesemia all predispose to toxicity. * **Treatment of choice:** Digibind (Digoxin-specific Fab fragments). Avoid DC cardioversion as it may precipitate ventricular fibrillation.

Q: Which of the following agents is NOT recommended in the treatment of aortic dissection?

Diazoxide. **Explanation:** The primary goal in managing aortic dissection is to reduce **shear stress** on the aortic wall. This is achieved by lowering both the systemic blood pressure and the rate of rise of the pressure pulse (**dP/dt**). **Why Diazoxide is NOT recommended:** Diazoxide is a potent arteriolar vasodilator. However, it causes **reflex tachycardia** and a compensatory increase in cardiac output and stroke volume. This increases the dP/dt (the force of ventricular contraction), which can worsen the intimal tear and propagate the dissection. Therefore, it is contraindicated. **Analysis of other options:** * **Beta-blockers (e.g., Esmolol):** These are the **first-line** agents. They decrease both heart rate and dP/dt, effectively reducing the shearing forces on the aorta. * **Labetalol:** This is a combined alpha and beta-blocker. It is highly effective as it reduces both systemic vascular resistance (via alpha-blockade) and the reflex tachycardia/contractility (via beta-blockade). * **Sodium Nitroprusside:** This is a potent vasodilator used to rapidly lower blood pressure. However, it must **always** be administered *after* or *concurrently* with a beta-blocker to prevent the reflex increase in dP/dt. **High-Yield Clinical Pearls for NEET-PG:** * **Target:** Aim for a systolic BP of 100–120 mmHg and a heart rate <60 bpm within 20 minutes. * **Sequence Matters:** Never give a pure vasodilator (like Nitroprusside or Hydralazine) alone; always ensure prior beta-blockade to protect the aorta from reflex sympathetic stimulation. * **Drug of Choice:** **IV Esmolol** is often preferred due to its short half-life, allowing for rapid titration.

Q: Which drug is not contraindicated in a pregnant lady for hypertension?

Hydralazine. In the management of hypertension during pregnancy, the primary goal is to ensure maternal safety without compromising fetal development or placental perfusion. **Hydralazine** is a direct-acting vasodilator that has been used for decades to manage hypertensive emergencies in pregnancy (e.g., pre-eclampsia) [2, 3]. It is considered safe because it does not have teratogenic effects and maintains adequate uterine blood flow [1]. **Analysis of Options:** * **Hydralazine (Correct):** It is a preferred parenteral agent for acute hypertensive crises in pregnancy. Along with **Labetalol** (drug of choice) and **Methyldopa** (safest for chronic hypertension), it forms the mainstay of treatment. * **Sodium Nitroprusside:** Generally contraindicated because its metabolism releases **cyanide**, which can lead to fetal cyanide poisoning and death. It is only used as a last resort when all other drugs fail. * **ACE Inhibitors (e.g., Enalapril):** These are strictly contraindicated (Category X/D). They cause **fetal dysgenesis**, including renal failure, oligohydramnios, skull hypoplasia, and pulmonary hypoplasia. * **Indapamide (Diuretics):** Diuretics are generally avoided in pregnancy because they can decrease maternal plasma volume, potentially leading to **placental hypoperfusion** and intrauterine growth restriction (IUGR). **NEET-PG High-Yield Pearls:** 1. **Drug of Choice (Chronic HTN in Pregnancy):** Oral Methyldopa (centrally acting alpha-2 agonist). 2. **Drug of Choice (Acute Hypertensive Crisis/Pre-eclampsia):** IV Labetalol is currently preferred over Hydralazine due to fewer side effects like reflex tachycardia. 3. **Teratogenic Risk:** ACE inhibitors and ARBs are most dangerous during the 2nd and 3rd trimesters due to their effects on the fetal renin-angiotensin system. 4. **Calcium Channel Blockers:** Nifedipine (long-acting) is also safe and frequently used.

Q: Which drug is contraindicated in hypertriglyceridemia?

Cholestyramine. The correct answer is **Cholestyramine**. **Mechanism and Contraindication:** Cholestyramine is a **Bile Acid Sequestrant (BAS)** [2]. It works by binding bile acids in the intestine, preventing their enterohepatic circulation [2]. This depletion of bile acids triggers the liver to convert more cholesterol into bile acids, thereby upregulating LDL receptors and lowering serum LDL. However, the compensatory increase in hepatic cholesterol synthesis is accompanied by a **concomitant increase in VLDL (Very Low-Density Lipoprotein) production** [1]. In patients with pre-existing hypertriglyceridemia, this leads to a significant rise in serum triglyceride (TG) levels, potentially precipitating acute pancreatitis. Therefore, BAS are contraindicated if baseline TG levels are >300 mg/dL [1]. **Analysis of Incorrect Options:** * **A. Fibrates (e.g., Fenofibrate):** These are the **drugs of choice** for severe hypertriglyceridemia. They activate PPAR-α, increasing lipoprotein lipase (LPL) activity and decreasing TG levels. * **B. Simvastatin:** Statins primarily lower LDL but also have a modest TG-lowering effect (10–30%). They are not contraindicated; rather, they are often used in mixed dyslipidemia. * **C. Niacin (Nicotinic Acid):** This is one of the most effective drugs for increasing HDL and is also very effective at lowering triglycerides by inhibiting lipolysis in adipose tissue. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for isolated hypertriglyceridemia:** Fibrates. * **Side effect of Cholestyramine:** Malabsorption of fat-soluble vitamins (A, D, E, K) and drugs like Warfarin or Digoxin. * **Most common side effect of Niacin:** Cutaneous flushing (mediated by Prostaglandin D2; prevented by Aspirin). * **Statin + Fibrate combination:** Increases the risk of **myopathy/rhabdomyolysis** (Gemfibrozil is more risky than Fenofibrate when combined with statins) [1].

Q: Headache is a commonly observed side effect of which anti-anginal drug class?

Nitrates. **Explanation:** **Why Nitrates are the Correct Answer:** Nitrates (e.g., Nitroglycerin, Isosorbide dinitrate) act as prodrugs that release **Nitric Oxide (NO)**. NO activates guanylyl cyclase, increasing cGMP levels, which leads to smooth muscle relaxation. While this effectively causes venodilation (reducing preload) and coronary vasodilation, it also causes significant **vasodilation of the meningeal and extracranial blood vessels**. This rapid stretching of the vessel walls and activation of perivascular pain fibers results in a characteristic throbbing headache, often referred to as a "Nitrate headache." **Analysis of Incorrect Options:** * **Beta blockers (A):** These drugs decrease heart rate and contractility. Their common side effects include bradycardia, fatigue, and bronchospasm, but they are actually used for migraine *prophylaxis*, not as a cause of headache. * **Trimetazidine (C):** A metabolic modulator that shifts myocardial metabolism from fatty acid oxidation to glucose oxidation. It is generally well-tolerated; its unique side effects are Parkinsonian-like symptoms (tremors/rigidity). * **Potassium channel openers (D):** While drugs like Nicorandil can cause headaches due to their nitrate-like moiety, Nitrates are the classic, more "commonly observed" prototype for this side effect in standard pharmacology curricula. **High-Yield Clinical Pearls for NEET-PG:** * **Nitrate Tolerance:** Continuous exposure leads to a loss of efficacy. A "nitrate-free interval" (8–12 hours) is essential to restore sensitivity. * **Monday Disease:** Historically, dynamite factory workers exposed to nitrates during the week developed headaches that disappeared over the weekend (due to tolerance) and returned on Monday. * **Contraindication:** Never co-administer Nitrates with **Sildenafil (PDE-5 inhibitors)**, as this can lead to catastrophic hypotension.

Q: Which of the following is an ultrashort acting beta-blocker devoid of partial agonistic or membrane stabilizing action?

Esmolol. **Explanation** **Esmolol** is the correct answer because it is a cardioselective (β1) antagonist characterized by its **ultrashort duration of action**. It has a half-life of approximately **9 minutes** due to its rapid hydrolysis by **red blood cell esterases**. Crucially, Esmolol lacks intrinsic sympathomimetic activity (partial agonistic action) and membrane stabilizing activity (local anesthetic effect), making it ideal for precise, minute-to-minute titration in acute settings. **Analysis of Incorrect Options:** * **Timolol (B):** A non-selective beta-blocker primarily used in glaucoma. It has a much longer half-life (approx. 4 hours) and is not considered ultrashort acting. * **Atenolol (C):** A cardioselective (β1) blocker with a long half-life (6–7 hours). It is water-soluble and excreted unchanged by the kidneys, unlike the esterase-metabolized Esmolol. * **Pindolol (D):** A non-selective beta-blocker notable for having significant **Intrinsic Sympathomimetic Activity (ISA)**, which the question specifically excludes. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** Esmolol is the only beta-blocker metabolized by **plasma esterases**, making it safe in patients with hepatic or renal impairment. * **Clinical Uses:** Preferred for intraoperative hypertension, supraventricular tachycardia (SVT) during surgery, and aortic dissection (to reduce shear stress). * **Mnemonic:** Remember **"Esmolol is Easy-in, Easy-out"** due to its rapid onset and offset. * **Other Ultrashort Drugs:** Similar to Esmolol, drugs like **Remifentanil** (opioid) and **Clevidipine** (CCB) are also metabolized by esterases.

Question 1

Why should a patient on verapamil not be given a beta-blocker?

Accepted Answer

Conduction block

Answer

Bronchospasm

Answer

Neurogenic shock

Answer

Anaphylaxis

Question 2

In a patient with poor glycemic control, hypertriglyceridemia, and low HDL, which of the following drug regimens would be best to manage dyslipidemia without the risk of myositis as a side effect?

Accepted Answer

Nicotinic acid

Answer

Fibric acid derivatives

Answer

Atorvastatin

Answer

Simvastatin

Question 3

Which of the following drugs is used for the prophylaxis of migraine but not for angina pectoris?

Accepted Answer

Flunarizine

Answer

Verapamil

Answer

Diltiazem

Answer

Amlodipine

Question 4

Which of the following is a true statement regarding Atrioventricular block with atrial tachycardia?

Accepted Answer

Seen in Digitalis toxicity with potassium depletion

Answer

Seen in Wolff-Parkinson-White syndrome

Answer

Is a complication of pacemaker insertion

Answer

Can occur in a normal person occasionally

Question 5

Which of the following statements is NOT true about ACE inhibitors?

Accepted Answer

Decreases potassium concentration

Answer

Contraindicated in asthma

Answer

Lacks postural hypotension

Answer

Does not affect quality of life

Question 6

Which of the following agents is NOT recommended in the treatment of aortic dissection?

Accepted Answer

Diazoxide

Answer

Beta blockers

Answer

Labetalol

Answer

Sodium nitroprusside

Question 7

Which drug is not contraindicated in a pregnant lady for hypertension?

Accepted Answer

Hydralazine

Answer

Sodium nitroprusside

Answer

ACE inhibitors

Answer

Indapamide

Question 8

Which drug is contraindicated in hypertriglyceridemia?

Accepted Answer

Cholestyramine

Answer

Fibrates

Answer

Simvastatin

Answer

Niacin

Question 9

Headache is a commonly observed side effect of which anti-anginal drug class?

Accepted Answer

Nitrates

Answer

Beta blockers

Answer

Trimetazidine

Answer

Potassium channel openers

Question 10

Which of the following is an ultrashort acting beta-blocker devoid of partial agonistic or membrane stabilizing action?

Accepted Answer

Esmolol

Answer

Timolol

Answer

Atenolol

Answer

Pindolol

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?